PMC:7696151 / 41748-41978 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1175","span":{"begin":35,"end":38},"obj":"Chemical"},{"id":"1179","span":{"begin":116,"end":173},"obj":"Disease"}],"attributes":[{"id":"A1175","pred":"tao:has_database_id","subj":"1175","obj":"MESH:D006886"},{"id":"A1179","pred":"tao:has_database_id","subj":"1179","obj":"MESH:D002318"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"i-phospholipid syndrome. Moreover, HCQ was revealed to be effective in preclinical and clinical trials to dampening autoimmune disease-dependent cardiovascular complications (Figure 7), as well as in the amelioration of disease-in"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T57","span":{"begin":116,"end":134},"obj":"Phenotype"}],"attributes":[{"id":"A57","pred":"hp_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"i-phospholipid syndrome. Moreover, HCQ was revealed to be effective in preclinical and clinical trials to dampening autoimmune disease-dependent cardiovascular complications (Figure 7), as well as in the amelioration of disease-in"}